Immunomodulatory properties of substance P: the gastrointestinal system as a model.
about
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposureRole of Corticotropin-releasing Factor in Gastrointestinal Permeability.Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis.Substance P modulates colitis-associated fibrosisNeurokinin-1 receptor antagonist treatment in polymicrobial sepsis: molecular insightsSubstance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locallySubstance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin actionRole of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patientsThe protective effects of total phenols in magnolia officinalix rehd. et wils on gastrointestinal tract dysmotility is mainly based on its influence on interstitial cells of cajalIncreased susceptibility of melanin-concentrating hormone-deficient mice to infection with Salmonella enterica serovar Typhimurium.Modulation of lymphatic muscle contractility by the neuropeptide substance PSubstance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.Substance P, obesity, and gut inflammation.Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets.Association of TNFSF15 polymorphism with irritable bowel syndrome.Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome.Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.Regulation of NK92-MI cell cytotoxicity by substance P.The Gut's Little Brain in Control of Intestinal Immunity.Secretion of immunomodulating neuropeptides (VIP, SP) and nitric oxide synthase in porcine small intestine during postnatal development.Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations.Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells.Increased corneal sub-basal nerve density in patients with Sjögren syndrome treated with topical cyclosporine A.Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.Localisation and activation of the neurokinin 1 receptor in the enteric nervous system of the mouse distal colon.Tumor progression: the neuronal input.Early protection from burn-induced acute lung injury by deletion of preprotachykinin-A gene.Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint.
P2860
Q28387506-1AF2688E-E4CA-4EA9-814A-286CE6ADC1DFQ30421083-A7D79102-153E-4DBD-BAEB-1E567C08757EQ33861196-5F6E23C5-5FD3-47AD-A4EC-840E2E6A7E4DQ34254416-22C87004-D845-47CC-92BE-37DFF70B0C4FQ34415133-830F9AEC-CAE1-4501-B0F6-0BD28728F901Q34718001-E054BAA0-8F6B-45AB-8BA3-D43F4A36278FQ35001343-692E6535-FA82-4D59-9974-80A7C8AED57AQ35590819-5DB33B11-5599-4079-B025-94CB76DDD97EQ35838055-E660E0A7-AF6F-4011-899F-5E72C21C5490Q36238054-8CEB3341-1C3E-440D-BBBB-495ABD9549D7Q36492678-9E69C09E-39DA-4E97-9456-0FEAA4020BF3Q36506045-4332A0C8-2CFA-4A4E-A143-D2D46B952B80Q36844549-CA5D850A-D503-4472-BE23-B5C31CE9304EQ37227039-459E39AC-E0B1-47C9-B881-2D23476374E3Q37356912-CBFF078A-6F48-43BC-9872-B16BB67F9E15Q37548872-ADCE0DA9-1BED-45CC-8F5A-B7743FE946CEQ37580090-7373C741-E632-44E8-914F-58A1C73BA395Q38224991-9251E13B-E7E2-4B29-86B9-C801EC21B3CEQ38253468-913E6B82-9A0B-46CE-9A76-74F6EFF17403Q38287054-8C04E76A-09E0-4090-9391-8E857F471BFEQ38531668-784F3623-44B4-4868-BB29-CB46526E9F7EQ38865042-0B9AA5F9-D0BF-426E-AFBD-C839EC44497DQ39581294-81D62387-9CAB-4370-9CD4-8AB20516EAE4Q40566816-BC7D03CA-07DD-4924-9C10-BF8F3FEABF02Q41307689-C1B769C7-7FD2-471A-B7D9-A075E4501D73Q42111894-5C7EBECB-FA78-4254-B63C-E4A65ED03CC9Q42252901-96FE6170-DD88-4FB6-B113-E73A4457C258Q42503008-A4A2DE77-FA56-47DC-8DE3-F3EB574052D2Q44652662-5867644A-7D0C-4DFC-88BF-6D55F36CA869Q46213275-097F8A65-A7FC-4F69-B59D-14310DCE094CQ52318550-CF60A532-3ED3-4A23-A39C-21C56FCF03C2Q52596063-7ACC8455-E9EF-4959-B19F-F602A867C256Q54255491-499590C7-6D83-4DA4-A1F4-9AAD5B86D24A
P2860
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@ast
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@en
type
label
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@ast
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@en
prefLabel
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@ast
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@en
P2860
P356
P1476
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
@en
P2093
Charalabos Pothoulakis
Hon Wai Koon
P2860
P356
10.1196/ANNALS.1366.024
P407
P577
2006-11-01T00:00:00Z